Picture of Oxford Nanopore Technologies logo

ONT Oxford Nanopore Technologies Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Oxford Nanopore Technologies, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-166-83.4-150-140-140
Depreciation
Amortisation
Non-Cash Items61.728.612.7-15.6-1.5
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital25.8-26.5-41.92.3821
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-53.8-49.4-137-110-70.6
Capital Expenditures-30.8-42.2-27.3-48.6-45.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-131-23.6-34.563.7102
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-162-65.8-61.81556.3
Financing Cash Flow Items-16.9-3.85-2.57-4.97-3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities623-13.764.773.6-2.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash407-131-136-21-18.4